ONWARD reveals ARC therapy spinal cord injury report
Implantable ARC therapy demonstrates potential to improve blood pressure regulation
Read MoreImplantable ARC therapy demonstrates potential to improve blood pressure regulation
Read MoreData reinforces potential to deliver new standards across HER2-targetable breast cancer
Read MorePartnership aims to progress personalised cancer therapy by incorporating doggybone DNA
Read MorePhase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema
Read MoreClinical trial has received regulatory approval and involves endometriosis candidate SN132D
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
